Merck KGaA Stock

Equities

MRK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate 08:15:28 2024-06-14 am EDT 5-day change 1st Jan Change
171.8 EUR -0.29% Intraday chart for Merck KGaA +0.44% +19.40%
Sales 2024 * 21.32B 22.8B Sales 2025 * 22.64B 24.21B Capitalization 74.91B 80.1B
Net income 2024 * 3B 3.2B Net income 2025 * 3.52B 3.77B EV / Sales 2024 * 3.8 x
Net Debt 2024 * 6.19B 6.62B Net Debt 2025 * 4.37B 4.67B EV / Sales 2025 * 3.5 x
P/E ratio 2024 *
25 x
P/E ratio 2025 *
21.1 x
Employees 62,345
Yield 2024 *
1.35%
Yield 2025 *
1.48%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Merck KGaA

1 day-0.26%
1 week+0.44%
Current month+3.33%
1 month+8.69%
3 months+7.67%
6 months+22.94%
Current year+19.40%
More quotes
1 week
169.50
Extreme 169.5
176.25
1 month
161.30
Extreme 161.3
176.25
Current year
140.50
Extreme 140.5
176.25
1 year
134.30
Extreme 134.3
176.25
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
61.05
Extreme 61.05
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 54 19-04-25
Members of the board TitleAgeSince
Director/Board Member - -
Chairman 67 19-04-25
Director/Board Member 62 90-12-31
More insiders
Date Price Change Volume
24-06-14 172 -0.15% 51 222
24-06-13 172.3 -2.02% 332,610
24-06-12 175.8 +2.36% 344,307
24-06-11 171.8 -0.06% 198,209
24-06-10 171.9 +0.35% 151,028

Delayed Quote Xetra, June 14, 2024 at 08:00 am EDT

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
172.3 EUR
Average target price
186.1 EUR
Spread / Average Target
+7.99%
Consensus